Boardroom Alpha
Boardroom Alpha
EMR · Current Report (Form 8-K) · Filed November 14, 2025

Emerson Electric Co — Current Report (Form 8-K)

Form
8-K
Filed
November 14, 2025
Period
Nov 13, 2025
Ticker
EMR
Accession
0000032604-25-000091
Boardroom Alpha · Filing insights

Emerson grants special performance-based stock options to CEO and COO with multi-price vesting.

About Emerson Electric Co
Market cap
$79.5B
1Y TSR
+11.1%
3Y TSR
+19.4%
Board grade
B-
Sector
Industrials
CEO
Surendralal L Karsanbhai
Last annual meeting: Feb 3, 2026 · View full Emerson Electric Co profile →
emr-20251113

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_______________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event
reported): November 13, 2025)
Emerson Electric Co.
-------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
Missouri1-27843-0259330
---------------------------------
(State or Other Jurisdiction of Incorporation)
-------------------
(Commission
---------------------------
(I.R.S. Employer Identification Number)
File Number)
8027 Forsyth Blvd. 
St. Louis,Missouri63105
------------------------------------------------
(Address of Principal Executive Offices)
------------------
(Zip Code)
Registrant’s telephone number, including area code:
(314) 553-2000
------------------------------------------
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s)Name of each exchange on which registered
Common Stock of $0.50 par value per share EMRNew York Stock Exchange
NYSE Texas
2.000% Notes due 2029EMR 29New York Stock Exchange
3.000% Notes due 2031EMR31ANew York Stock Exchange
3.500% Notes due 2037EMR 37New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    



Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On November 13, 2025, the Compensation Committee (the “Committee”) of the Board of Directors of Emerson Electric Co. (“Emerson”, “our” or “the Company”) approved the grant of a Special Performance-based Award to our President and Chief Executive Officer, Lal Karsanbhai, and to our Executive Vice President and Chief Operating Officer, Ram Krishnan.
Under the leadership and strategic vision of Messrs. Karsanbhai and Krishnan, Emerson has accelerated the automation focused transformation of the Company, positioning the Company for higher growth, more resilience, and differentiation through its software-defined technology stack combined with hardware-advantaged solutions and robust financial and operational performance. Considering the critical roles of Messrs. Karsanbhai and Krishnan in implementing our go-forward strategy, the Committee designed the Special Performance-based Awards to incentivize and support the continued success of our repositioned portfolio and the creation of long-term shareholder value.
The Special Performance-based Awards were granted in the form of long-term, performance-based stock options, with the exercise price for 80% of the awards set at a significant premium to the fair market value of our common stock as of the grant date. Pursuant to this performance-based award structure, which was designed by the Committee with advice and input from the Committee’s independent compensation consultant, Exequity LLP, our shareholders must realize significant appreciation in our stock price in order for Messrs. Karsanbhai and Krishnan to receive the full value of the awards. Accordingly, the Committee believes these awards further strengthen the link between the long-term interests of Messrs. Karsanbhai and Krishnan and our shareholders, support leadership continuity, and align with Emerson’s pay-for-performance philosophy.
Under the Special Performance-based Awards, on November 13, 2025, each of Mr. Karsanbhai and Mr. Krishnan were awarded an aggregate of 350,000 stock options, consisting of 70,000 stock options with an exercise price of $128.46 per share, the closing price of a share of our common stock on the NYSE on the grant date, 70,000 stock options with an exercise price of $160.575 per share, which represented a 25% premium over the closing price of a share of our common stock on the NYSE on the grant date, 70,000 stock options with an exercise price of $192.69 per share, which represented a 50% premium over the closing price of a share of our common stock on the NYSE on the grant date, 70,000 stock options with an exercise price of $224.805 per share, which represented a 75% premium over the closing price of a share of our common stock on the NYSE on the grant date and 70,000 stock options with an exercise price of $256.92 per share, which represented a 100% premium over the closing price of a share of our common stock on the NYSE on the grant date.
Each tranche of 70,000 stock options vests pro rata over a period of five years on the anniversary of the date of grant, such that 14,000 stock options at each exercise price would vest each year. The stock options are generally subject to continued employment through the applicable vesting date and must be exercised within 10 years of the grant date. The stock options are subject to accelerated vesting in the event of death or disability or on a “double-trigger” basis in connection with a change in control, as provided in the Company’s shareholder approved 2024 Equity Incentive Plan (“Plan”). The awards also include confidentiality, non-competition, and non-solicitation obligations.




SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 EMERSON ELECTRIC CO.
(Registrant)
  
Date:November 14, 2025By:/s/ John A. Sperino
  
John A. Sperino
Vice President and
Assistant Secretary

  

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Emerson Electric Co (EMR)

Reference

Frequently asked questions

When did Emerson Electric Co file this 8-K?
Emerson Electric Co (EMR) filed this Current Report (Form 8-K) with the SEC on November 14, 2025. The accession number assigned by EDGAR is 0000032604-25-000091.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Emerson grants special performance-based stock options to CEO and COO with multi-price vesting. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Emerson Electric Co's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Emerson Electric Co has filed under CIK 32604, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer